[VRTX] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
23-Feb-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- 79.92%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 4,162,821 3,047,597 2,488,652 1,702,177 1,032,336 580,415 1,211,975 22.82%
PBT 1,394,919 600,241 -15,689 -67,366 -559,581 -734,875 -976,117 -
Tax 218,109 -1,486,862 -107,324 16,665 30,381 6,958 -288,567 -
NP 1,176,810 2,096,896 263,484 -112,052 -558,115 -738,555 -445,028 -
Tax Rate -15.64% 247.71% - - - - - -
Total Cost 2,986,011 950,701 2,225,168 1,814,229 1,590,451 1,318,970 1,657,003 10.30%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 28.27 68.80 10.59 -6.58 -54.06 -127.25 -36.72 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS 4.58 8.25 1.06 -0.46 -2.32 -3.14 -1.98 -
EPS Diluted 4.51 8.09 1.04 -0.46 -2.31 -3.14 -1.98 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.